 | DexCom, Inc. | |||
| NMS : DXCM || Location: United States | ||||
$130.71-3.59 (-2.67%) |
2.85 M | 129.17 - 135.06 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 14.572 M |
| March 15, 2024 | 15.867 M |
| Feb. 29, 2024 | 16.648 M |
| Feb. 15, 2024 | 17.070 M |
| Jan. 31, 2024 | 18.561 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.44 | 0.50 | 13.61% |
| 09/30/2023 | 0.35 | 0.50 | 43.84% |
| 06/30/2023 | 0.23 | 0.34 | 47.38% |
| 03/31/2023 | 0.15 | 0.17 | 13.79% |
| 12/31/2022 | 0.28 | 0.34 | 22.39% |
DXCM Basic Data
| Sector | Healthcare | Industry | Medical Devices |
| Shares Outstanding | 385.515M | Shares Float | 379.713M |
| Short Float | 14.572M | Market Cap | 50390.67M |
| Institution ownership | 0.00% | Insider ownership | 0.411% |
| Earnings Date | 04/25/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 1.29 | Forward EPS | 2.23 |